We focus on equity investments in biotech companies possessing pioneering technologies and competencies that hold the potential to influence the future of the pharmaceutical industry.
Our aims are:
We base our activities on the scientific, technological and commercial competencies available within Novo Nordisk
We provide the opportunity for the talented entrepreneur to benefit from these resources available at Novo Nordisk
We are dedicated to adding value to our investment partners through dialogue with their management team, thereby providing value towards a successful commercialisation and maturation.